Sat.Dec 02, 2023

article thumbnail

The ICH Q9 Revision and a Renewed Focus on Quality Risk Management Fundamentals

PharmaTech

The ICH Q9 revision clarifies QRM implementation for the pharmaceutical industry and expands descriptions of methodology, formality, and risk-based decision making to provide the industry with a solid base from which to build their own QRM programs.

article thumbnail

Final Product Inspection: Making the Most of Your Processes

PharmaTech

Final product inspection results should be included as part of the batch release documentation, says Susan J. Schniepp, distinguished fellow at Nelson Laboratories, LLC.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Revitalizing Quality Management Processes through Digitalization

PharmaTech

Eradicating paper-based workflows and standalone solutions operating in isolation provides a good starting point to update quality management processes.

article thumbnail

Establishing a Framework for Reliable Pharma Labeling

PharmaTech

By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.

Pharma 52
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Stability Studies: An Essential Step for Quality Management in Drug Development

PharmaTech

Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.

article thumbnail

Falling Short

PharmaTech

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.

More Trending

article thumbnail

Elaboration, Expansion, and Evolution in Outsourcing of Clinical Research

PharmaTech

The rising complexity of clinical research protocols has necessarily expanded the CRO landscape.

52
article thumbnail

Training for Operational Excellence

PharmaTech

The bio/pharmaceutical industry is struggling with the challenge of staffing and training.

article thumbnail

Risks and Rewards of Investing in RNA-based Genetic Medicine Manufacturing

PharmaTech

Collaboration is a key component to achieving long-term success with genetic medicines.

article thumbnail

Revolutionizing Biomanufacturing: The Digitalization Advantage

PharmaTech

Digital transformation allows for smarter and connected biomanufacturing operations.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Signing Off from Washington

PharmaTech

FDA and industry face unprecedented political and policy challenges.

FDA 52
article thumbnail

Selecting Excipients for Enhancing Solubility of Hot-Melt Extrusion Formulations

PharmaTech

Matching excipients to API properties is essential.

52
article thumbnail

Renewing the UK Voluntary Pricing Scheme

PharmaTech

What does the 2024 VPAS mean for pharma?

Pharma 52